Second-quarter report 2026

Q2 orders surged 27% to MSEK 50,951 (organic +26%), while revenues were MSEK 44,974 vs MSEK 41,210 (organic +8%). Operating profit rose to MSEK 9,249 (from MSEK 8,493), keeping margins at 20.6% (with adjusted operating profit up to MSEK 9,455 and adjusted margin improving to 21.0% from 20.4%). Overall, the growth in profitability alongside strong order momentum is a positive read-through for near-term performance.

Analysis

The key signal is not the headline growth rate; it’s the divergence between orders and revenue. That usually means backlog is still building, which supports forward sales visibility for the next 1-2 quarters, but also delays the P&L payoff because conversion, not intake, is what drives near-term estimate upgrades. In capital goods, that setup tends to re-rate the stock only when investors see sustained book-to-bill above 1 and evidence that incremental revenue is converting into margin expansion rather than just absorbing fixed costs.

The margin print matters more than the top line: holding a ~21% operating margin with mid-single-digit organic revenue growth suggests pricing and mix are still doing work, which is constructive for peers with similar aftermarket exposure and manufacturing leverage. The second-order winner is likely the broader industrial supplier chain if this is part of a wider capex upcycle; the loser is any competitor relying on price cuts to defend share, because a firm with order momentum can be more selective on discounting and lock in better gross margin quality over time.

The contrarian risk is that order strength is being misread as a clean demand signal. In this sector, orders can be lumpy, tied to a few large projects, and can reverse quickly if customer capex budgets get re-phased; the real falsifier is whether organic revenue growth accelerates over the next 1-2 quarters and whether margin expands beyond this plateau. If not, the market may eventually punish the stock for working-capital intensity and a slower-than-expected earnings conversion despite strong bookings.

Key Decisions for Investors

• Watchlist, not immediate trade: wait 1 quarter for evidence that revenue growth closes the gap to order growth; if backlog converts and margins expand, that is the point to add exposure to the name or its closest Nordic capital-goods peer group.
• Pair trade idea: long industrial-capex beneficiaries with visible backlog support, short more cyclical manufacturing beta (e.g., XLI vs. IWM) for the next 1-3 months; the thesis is that order strength in higher-quality industrials should outperform small-cap cyclicals if macro data stays soft.
• If owning the broader industrial basket, overweight order-driven, high-margin names and underweight low-margin commodity manufacturers for the next earnings season; the spread should widen if pricing discipline holds.
• Set an alert for the next report’s organic revenue growth and operating margin: if revenue remains below order growth by more than ~10 percentage points or margin slips below the current run-rate, treat that as a sign the order book is not translating into earnings power.
• No options recommendation yet: implied move is likely modest unless management raises guidance; a call structure only becomes attractive if there is explicit commentary on backlog quality, capex demand duration, or margin expansion into H2.